PCM
STIM icon

Prelude Capital Management’s Neuronetics STIM Stock Holding History

Prelude Capital Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20,010
Closed -$73.6K – 1334
2025
Q1 		$73.6K Buy
+20,010
New +$73.1K 0.01% 1066
2024
Q3 		– Sell
-46,219
Closed -$83.2K – 1527
2024
Q2 		$83.2K Sell
46,219
-308
-0.7% -$888 0.01% 1118
2024
Q1 		$221K Buy
+46,527
New +$164K 0.01% 1058
2023
Q3 		– Sell
-160,808
Closed -$346K – 1337
2023
Q2 		$346K Sell
160,808
-20,255
-11% -$49.1K 0.02% 587
2023
Q1 		$527K Sell
181,063
-84,546
-32% -$426K 0.03% 447
2022
Q4 		$1.82M Sell
265,609
-31,812
-11% -$150K 0.09% 234
2022
Q3 		$946K Sell
297,421
-1,900
-0.6% -$6.91K 0.03% 450
2022
Q2 		$961K Buy
299,321
+17,258
+6% +$50.1K 0.03% 544
2022
Q1 		$855K Buy
282,063
+12,063
+4% +$40.8K 0.02% 651
2021
Q4 		$1.2M Buy
270,000
+45,312
+20% +$222K 0.03% 518
2021
Q3 		$1.47M Buy
224,688
+91,485
+69% +$877K 0.04% 415
2021
Q2 		$2.13M Buy
+133,203
New +$1.84M 0.06% 279
2020
Q4 		– Sell
-36,080
Closed -$175K – 1946
2020
Q3 		$175K Buy
36,080
+35,830
+14,332% +$136K 0.01% 726
2020
Q2 		$0 Buy
+250
New +$513 ﹤0.01% 2237
2019
Q4 		– Sell
-9,700
Closed -$81K – 2229
2019
Q3 		$81K Buy
9,700
+9,181
+1,769% +$100K ﹤0.01% 1021
2019
Q2 		$6K Buy
+519
New +$7.33K ﹤0.01% 1506
2018
Q4 		– Sell
-20,912
Closed -$670K – 2132
2018
Q3 		$670K Buy
20,912
+4,912
+31% +$149K 0.04% 454
2018
Q2 		$426K Buy
+16,000
New +$435K 0.03% 581

Other funds holding STIM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

Prelude Capital Management's STIM Position: Q2 2025 in Review

Prelude Capital Management sold out of Neuronetics (STIM) in Q2 2025, closing a stake of 20,010 shares — an estimated $73.6K sold.

Prelude Capital Management first reported a position in STIM in Q2 2018 and held it in 18 quarters. The position peaked at $2.13M in Q2 2021. 90 funds tracked by Wall St. Rank hold STIM as of Q2 2025.

  • Prelude Capital Management reported no remaining Neuronetics position as of Q2 2025 after selling out during the quarter.
  • Prelude Capital Management sold 20,010 Neuronetics shares in Q2 2025, an estimated $73.6K.
  • Prelude Capital Management first reported a position in Neuronetics in Q2 2018 and held it in 18 quarters.
  • Prelude Capital Management's Neuronetics position peaked at $2.13M in Q2 2021.
  • 90 funds tracked by Wall St. Rank held Neuronetics as of Q2 2025.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.